CRL vs HYPD · rev $4.05B vs rev $57.3K
Charles River Laboratories (CRL) versus Hyperion DeFi, Inc. (HYPD) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Hyperion DeFi, Inc. (HYPD) is a biotechnology company listed on NASDAQ.
Latest reported CRL revenue for 2024-12-28 was $4.05B. Net income was $25.3M. Revenue was down 1.9% from 2023-12-30 to 2024-12-28. CRL currently screens at market cap $7.78B.
Latest reported HYPD revenue for 2024-12-31 was $57.3K. Net income was -$49.8M. Revenue was up 1414.0% from 2023-12-31 to 2024-12-31. HYPD currently screens at market cap $48.5M.
CRL currently screens at market cap $7.78B. HYPD currently screens at market cap $48.5M.
Not investment advice. Open the CRL and HYPD stock pages for the full models.
Not investment advice.